Status:
COMPLETED
90-Day Mortality After Emergency Department Discharge in Advanced Cancer
Lead Sponsor:
Ankara Etlik City Hospital
Conditions:
Advanced Cancer
Mortality
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective observational study investigates factors associated with 90-day mortality among patients with advanced cancer who present to the emergency department (ED). The study will include st...
Detailed Description
Patients with advanced-stage cancer frequently present to emergency departments (EDs) due to complications related to disease progression, treatment side effects, or acute clinical deterioration. Such...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Pathologically confirmed stage IV (metastatic) solid malignancy
- Followed at Etlik City Hospital, Department of Medical Oncology
- Presented to the emergency department between December 2022 and March 2025
- Either discharged on the same day, admitted to the hospital, or died during the ED visit
- Received systemic anticancer therapy (chemotherapy, immunotherapy, targeted therapy, or hormonal therapy) within the past 6 months
- Availability of complete clinical and laboratory data
Exclusion
- Stage I-III cancer patients
- Patients not receiving systemic therapy, only palliative/supportive care
- Patients followed in other oncology centers but presenting to Etlik City Hospital ED
- Patients with hematologic malignancies (e.g., leukemia, lymphoma, multiple myeloma)
- Patients with missing clinical or laboratory data
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
1250 Patients enrolled
Trial Details
Trial ID
NCT07167095
Start Date
December 1 2022
End Date
March 1 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye), 06210